4//SEC Filing
FARES Wassim 4
Accession 0001600132-20-000105
CIK 0001600132other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 4:04 PM ET
Size
5.4 KB
Accession
0001600132-20-000105
Insider Transaction Report
Form 4
FARES Wassim
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-09-10$10.12/sh+30,000$303,600→ 30,000 totalExercise: $10.12Exp: 2030-09-10→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the underlying shares on August 11, 2021 and the remaining options vest quarterly over a period of 3 years thereafter.
Documents
Issuer
Bellerophon Therapeutics, Inc.
CIK 0001600132
Entity typeother
Related Parties
1- filerCIK 0001824106
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 4:04 PM ET
- Size
- 5.4 KB